Santhera Pharmaceuticals

Santhera Pharmaceuticals is a Swiss specialty pharmaceutical company dedicated to developing and marketing innovative treatments for mitochondrial and neuromuscular diseases, areas with significant unmet medical needs.

Dario Eklund

CEO

Thomas Meier Ph.D

CEO

1 past transactions

Juvantia Pharma

Acquisition in 2009
Juvantia Pharma is discovers and develops pharmaceutical products for neurological and cardiovascular disorders. The company focuses on small molecule pharmaceuticals active on G-protein coupled receptors.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.